![Western Blot: ITIH4 Antibody (CL1858) [NBP2-34492] - Lane 1: Marker [kDa]. Lane 2: Human liver tissue lysate](http://images.novusbio.com/fullsize/ITIH4-Antibody-CL1858-Western-Blot-NBP2-34492-img0006.jpg "Western Blot: ITIH4 Antibody (CL1858) [NBP2-34492] - Lane 1: Marker [kDa]. Lane 2: Human liver tissue lysate")
| Reactivity | HuSpecies Glossary |
| Applications | WB, IHC |
| Clone | CL1858 |
| Clonality | Monoclonal |
| Host | Mouse |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Immunogen | This antibody was developed using a recombinant protein derived from Q14624, with the exact immunogen sequence remaining proprietary. |
| Isotype | IgG1 |
| Clonality | Monoclonal |
| Host | Mouse |
| Gene | ITIH4 |
| Purity | Protein A purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | For IHC-Paraffin, HIER pH 6 retrieval is recommended. |
||
| Control Peptide |
|
||
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS (pH 7.2) and 40% Glycerol |
| Preservative | 0.02% Sodium Azide |
| Purity | Protein A purified |
| Publication using NBP2-34492 | Applications | Species |
|---|---|---|
| Lee EJ, Yang SH, Kim KJ et al. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma. Cancer Res Treat 2018-07-01 [PMID: 28724284] (IHC-Fr, Human) | IHC-Fr | Human |
Secondary Antibodies |
Isotype Controls |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human cerebellum shows absence of immunoreactivity (negative control).](http://images.novusbio.com/fullsize/ITIH4-Antibody-CL1858-Immunohistochemistry-NBP2-34492-img0004.jpg "Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human cerebellum shows absence of immunoreactivity (negative control).")
![Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human liver shows immunoreactivity in sinusoids.](http://images.novusbio.com/fullsize/ITIH4-Antibody-CL1858-Immunohistochemistry-NBP2-34492-img0001.jpg "Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human liver shows immunoreactivity in sinusoids.")
![Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human fallopian tube shows strong immunoreactivity in blood vessels and in plasma.](http://images.novusbio.com/fullsize/ITIH4-Antibody-CL1858-Immunohistochemistry-NBP2-34492-img0002.jpg "Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human fallopian tube shows strong immunoreactivity in blood vessels and in plasma.")
![Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human kidney (renal cancer) shows strong positivity in plasma in blood vessels.](http://images.novusbio.com/fullsize/ITIH4-Antibody-CL1858-Immunohistochemistry-NBP2-34492-img0003.jpg "Immunohistochemistry: ITIH4 Antibody (CL1858) [NBP2-34492] - Staining of human kidney (renal cancer) shows strong positivity in plasma in blood vessels.")
![Flow Cytometry CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Flow_Cytometry_22407.jpg)
![Neutralization CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Block_Neutralize_9044.jpg)
![Immunocytochemistry CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Immunocytochemistry_9681.jpg)
![Immunohistochemistry CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Immunohistochemistry_6955.jpg)
![Neutralization CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Block_Neutralize_9041.jpg)
![Immunohistochemistry CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Immunohistochemistry_19917.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![Bioactivity IL-2 [Unconjugated]](https://images.novusbio.com/images/202-il_recombinant-human-il-2-protein-bioactivity-174202314946.jpg)
![Immunohistochemistry Glycophorin A Antibody (R10) [Unconjugated]](https://images.novusbio.com/images2/Glycophorin_A_MAB1228_Immunohistochemistry_19187.jpg)
![Flow Cytometry Glycophorin A Antibody (R10) [Unconjugated]](https://images.novusbio.com/images2/Glycophorin_A_MAB1228_Flow_Cytometry_19288.jpg)
![Bioactivity CTLA-4 [Unconjugated]](https://images.novusbio.com/images2/CTLA4_7268CT_2293.jpg)
![SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.](https://images.novusbio.com/images/Mouse-IgG1-Isotype-Control-MG1-SDS-Page-NBP1-97005-img0002.jpg "SDS-Page: Mouse IgG1 Isotype Control (MG1) [NBP1-97005] - Lane 1: , Non-reduced. M: Opal Pre-stained Ladder. Lane 2: , Reduced. Load: 1.0 ug per lane. Predicted/Observed: 120 kDa Non-reduced, 55 and 25 Reduced.")